arrow
Back
P

Pablo Tebas

harvard university medical affiliates

77H-index
375Paper Count
2.0WCitation Count
Published Papers 169
Publication Date
Are screening periods in ART-naive trials justified in the era of rapid ART?
err2026-05-14
err0
PREAI
errWilliam R Short; Serena Koenig; Pablo Tebas; Monica Gandhi
errShare
errSave
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults
err2026-04-01
err0
PREAI
errShumaker, Amy Hirsch; Bhimraj, Adarsh; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Shafer, Robert W.; Tien, Phyllis C.; Baden, Lindsey R.; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Hardy, Erica J.; Johnson, Steven; Kim, Arthur Y.; Macbrayne, Christine; Martin, Greg S.; Nadig, Nandita; Nakamura, Mari M.; Oliveira, Carlos R.; Pearson, Jeffrey C.; Riley, Laura; Shoham, Shmuel; Tebas, Pablo; Willis, Zachary; Wolf, Joshua; Loveless, Jennifer; Morgan, Rebecca L.; Falck-Ytter, Yngve; Gandhi, Rajesh T.
errShare
errSave
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab
err2026-04-01
err0
PREAI
errNadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Macbrayne, Christine; Nakamura, Mari M.; Oliveira, Carlos R.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Willis, Zachary; Wolf, Joshua; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T.
errShare
errSave
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial
err2025-10-21
err0
errOAAI
errPablo Tebas; Ami Patel; Joseph T. Agnes; Elizabeth M. Parzych; Amanda Baer; Maria Caturla; Sukanya Ghosh; Mansi Purwar; Nicole Bedanova; Chungdhak Tsang; Knashawn Morales; Dinah Amante; Paul D. Fisher; Joseph R. Francica; Laurent Humeau; Daniel W. Kulp; Jesper Pallesen; Paul Leon; Mark Esser; Trevor R. F. Smith; David B. Weiner
errShare
errSave
Retinol Binding Protein 4 reactivates latent HIV-1 by triggering canonical NF-κB, JAK/STAT5 and JNK signalling
err2025-10-03
err0
errOAAI
errChiara Pastorio; Khumoekae Richard; Shariq Usmani; Ann-Kathrin Kissmann; Grigory Bolotnikov; Guillermo Gosálbez; Manuel Hayn; Lennart Koepke; Alina Sauertnik; Andrea Preising; Nico Preising; Ludger Ständker; Matthew Fair; Jessicamarie Morris; Emmanouil Papasavvas; Qin Liu; Honghong Sun; Armando Rodríguez; Karam Mounzer; Sebastian Wiese; Pablo Tebas; Yangzhu Du; Gregory M. Laird; Markus Jaritz; Frank Rosenau; Moritz M. Gaidt; Konstantin M. J. Sparrer; Luis J. Montaner; Frank Kirchhoff
errShare
errSave
Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies
err2025-10-01
err0
errOAAI
errMcMyn, Natalie F.; Varriale, Joseph; Wu, Hanna W. S.; Hariharan, Vivek; Moskovljevic, Milica; Tan, Toong Seng; Lai, Jun; Singhal, Anushka; Lynn, Kenneth; Mounzer, Karam; Tebas, Pablo; Montaner, Luis J.; Hoh, Rebecca; Yu, Xu G.; Lichterfeld, Mathias; Simonetti, Francesco R.; Kovacs, Colin; Deeks, Steven G.; Siliciano, Janet M.; Siliciano, Robert F.
errShare
errSave
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness
err2025-10-01
err0
errOAAI
errBhimraj, Adarsh; Falck-Ytter, Yngve; Baden, Lindsey R.; Bedimo, Roger; Cawcutt, Kelly; Cheng, Vincent Chi-Chung; Chew, Kara W.; Chiotos, Kathleen; Daar, Eric S.; Dzierba, Amy L.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Kim, Arthur Y.; Li, Jonathan Z.; MacBrayne, Christine; Martin, Greg S.; Nadig, Nandita; Nakamura, Mari M.; Pearson, Jeffrey C.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Shumaker, Amy Hirsch; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Morgan, Rebecca L.; Gandhi, Rajesh T.
errShare
errSave
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept
err2025-09-01
err0
errOAAI
errNadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; Macbrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T.
errShare
errSave
Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence
errImmunity
IF26.3
err2025-08-21
err0
errOAAI
errYulong Wei; Haocong Katherine Ma; Michelle E. Wong; Hyein Back; Emmanouil Papasavvas; Karam Mounzer; Faten Aberra; Ricardo Morgenstern; Pablo Tebas; Liza Konnikova; Luis J. Montaner; Ya-Chi Ho
errShare
errSave
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab
err2025-08-01
err1
errOAAI
errNadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; Macbrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T.
errShare
errSave
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With Human Immunodeficiency Virus Type 1: ACTG A5357
err2025-08-01
err1
PREAI
errTaiwo, Babafemi O.; Zheng, Yu; Rodriguez, Katherine; Burke, Leah; Reeves, Jacqueline D.; Scarsi, Kimberly K.; Gama, Lucio; Petropoulos, Christos J.; Belaunzaran-Zamudio, Pablo F.; Wannamaker, Paul; D'Amico, Ronald; Rathod, Parita; Bar, Katharine J.; Tebas, Pablo
errShare
errSave
Understanding the clinical implications of low-level viremia in ART-treated individuals
errAIDS
IF3.1
err2025-07-31
err0
PREAI
errConway, Briana, b; Tebas, Pabloc; Slama, Laurenced
errShare
errSave
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab
err2025-07-01
err1
errOAAI
errNadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; MacBrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T.
errShare
errSave
errShare
errSave
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
err2025-02-24
err0
errOAAI
errHappe, Myra; Lynch, Rebecca M.; Fichtenbaum, Carl J.; Heath, Sonya L.; Koletar, Susan L.; Landovitz, Raphael J.; Presti, Rachel M.; Santana-Bagur, Jorge L.; Tressler, Randall L.; Holman, LaSonji A.; Novik, Laura; Roa, Jhoanna C.; Rothwell, Ro Shauna; Strom, Larisa; Wang, Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M.; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M.; Pandey, Janardan P.; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R.; Lin, Bob C.; Mcdermott, Adrian B.; Boritz, Eli A.; Capparelli, Edmund V.; Coates, Emily E.; Koup, Richard A.; Ledgerwood, Julie E.; Mascola, John R.; Chen, Grace L.; Tebas, Pablo
errShare
errSave
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned
err2024-11-01
err0
PREAI
errGulick, Roy M.; Pau, Alice K.; Daar, Eric; Evans, Laura; Gandhi, Rajesh T.; Tebas, Pablo; Ridzon, Renee; Masur, Henry; Lane, H. Clifford
errShare
errSave
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis
err2024-10-29
err1
PREAI
errBhimraj, Adarsh; Falck-Ytter, Yngve; Kim, Arthur Y.; Li, Jonathan Z.; Baden, Lindsey R.; Johnson, Steven; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Chiotos, Kathleen; Daar, Eric S.; Dzierba, Amy L.; Glidden, David, V; Hardy, Erica J.; Martin, Greg S.; Macbrayne, Christine; Nadig, Nandita; Nakamura, Mari M.; Shumaker, Amy Hirsch; Tien, Phyllis; Loveless, Jennifer; Morgan, Rebecca L.; Gandhi, Rajesh T.
errShare
errSave
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 Antibodies
err2024-10-23
err0
PREAI
errPahus, Marie Host; Zheng, Yu; Olefsky, Maxine; Gunst, Jesper Damsgaard; Tebas, Pablo; Taiwo, Babafemi; Sogaard, Ole S.; Peluso, Michael J.; Lie, Yolanda; Reeves, Jacqueline D.; Petropoulos, Christos J.; Caskey, Marina; Bar, Katharine J.
errShare
errSave
Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center
err2024-07-10
err0
errOAAI
errHamilton, Keith W.; Hua, Elvis; Dutcher, Lauren; Fernandez Lynch, Holly; Junker, Paul; Doucette, Abigail G.; Werner, Danielle; Kannel, Ethan Z.; Civitello, Thomas; Gabriel, Peter; Ahya, Vivek N.; Jacobs, Dina A.; Garfall, Alfred; Pratz, Keith; Degnan, Kathleen O.; Blumberg, Emily A.; Capozzi, Donna; Craig, Ethan; Takach, Patricia; Payne, Aimee S.; Geara, Abdallah; Koenig, Helen; Holzman, Lawrence; Tebas, Pablo
errShare
errSave
Switch to fixed-dose doravirine (100 mg) with islatravir (075 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial
err2024-06-01
err6
PREAI
errMolina, Jean-Michel; Rizzardini, Giuliano; Orrell, Catherine; Afani, Alejandro; Calmy, Alexandra; Oka, Shinichi; Hinestrosa, Federico; Kumar, Princy; Tebas, Pablo; Walmsley, Sharon; Grandhi, Anjana; Klopfer, Stephanie; Gendrano, Isaias; Eves, Karen; Correll, Todd A.; Fox, Michelle C.; Kim, Jason
errShare
errSave